Shiferman Gregory L. sold SAGE
March 24, 2025 · Form 4 insider transaction
Shiferman Gregory L. sold 79 shares of SAGE Therapeutics Holdings at $8.21 per share, a transaction worth $648.59. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
79
Price
$8.21
Total value
$648.59
InsiderShiferman Gregory L.
RoleOfficer
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateMarch 24, 2025
Filing dateMarch 26, 2025
Shares owned after30,680
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
On March 24, 2025, the reporting person vested 235 shares of time-based restricted stock units (RSUs) granted on October 28, 2021 under the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan. This grant vested 25% on September 24, 2022, and vests quarterly thereafter in twelve equal installments. Represents shares withheld to satisfy tax withholding obligations on the vesting of restricted stock units.